Translations:Research/key-initiatives/ras/spokes-funding/11/en

From loveco.care
Revision as of 23:27, 29 October 2019 by FuzzyBot (talk | contribs) (Importing a new version from external source)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Peter Jackson, Michael C. Bassik, and Alejandro Sweet-Cordero, Stanford University School of Medicine

Peter Jackson, Michael C. Bassik, and Alejandro Sweet-Cordero, Stanford University School of Medicine, for "Using Protein Interaction Networks and Combinatorial Screens to Target KRAS-driven Cancer." Drs. Jackson, Bassik, and Sweet-Cordero and their team will look for synthetic lethalities in non-small cell lung cancers expressing mutant KRAS. Proteomics and CRISPR-CAS9 screens will discover vulnerabilities that will be tested in mouse models and patient-derived xenografts.

Retrieved from "http://www.loveco.care/index.php?title=Translations:Research/key-initiatives/ras/spokes-funding/11/en&oldid=10498"